Revenue Growth Benchmarks
Top-line performance metrics of companies across industries and countries
Top 10 Oncology Pharma and Biotech Companies
Sales growth in the top 10 global pharmaceutical companies specializing in oncology therapy was modest over both the past 12 months (-2.5%) and 5 years (+6.9%), and generated revenues over $500 Bn.
[ 1: LTM Sales in USD Biliion | Red Shading: Companies with negative growth in period | Green Shading: Top 2 companies by growth rank in period ]
| Company | HQ | Reported | Latest | LTM | year-on-year % | CAGR | Growth Rank | ||||||||||||
| Currency | FQ | Sales1 | 3m | 6m | 9m | ltm | 1y | 2y | 3y | 5y | 6m | LTM | 3ycagr | 5ycagr | |||||
| Bristol-Myers Squibb Co | USA | USD | 2023-12 | 45.01 | 0.6% | -0.8% | -2.4% | -2.5% | -2.5% | -1.5% | 1.9% | 14.8% | 7 | 7 | 7 | 2 | |||
| Roche Holding AG | CHE | CHF | 2023-12 | 67.29 | na | -6.5% | na | -8.2% | -8.2% | -1.9% | 1.2% | 1.2% | 9 | 9 | 8 | 8 | |||
| Johnson & Johnson | USA | USD | 2023-12 | 93.02 | 7.3% | 7.0% | 6.8% | 6.5% | 6.5% | 4.0% | 1.0% | 0.9% | 3 | 3 | 9 | 9 | |||
| Merck & Co Inc | USA | USD | 2023-12 | 60.11 | 5.8% | 6.3% | 5.2% | 1.4% | 1.4% | 11.1% | 13.1% | 7.3% | 4 | 4 | 2 | 6 | |||
| Pfizer Inc | USA | USD | 2023-12 | 58.50 | -41.3% | -41.4% | -46.1% | -41.7% | -41.7% | -15.2% | 12.0% | 7.5% | 10 | 10 | 3 | 5 | |||
| AbbVie Inc | USA | USD | 2023-12 | 54.32 | -5.4% | -5.7% | -5.4% | -6.4% | -6.4% | -1.7% | 5.8% | 10.6% | 8 | 8 | 5 | 3 | |||
| Novartis AG | CHE | CHF | 2023-12 | 51.02 | -0.3% | 1.7% | 0.6% | 1.1% | -0.3% | -0.2% | -3.1% | -2.5% | 5 | 6 | 10 | 10 | |||
| AstraZeneca PLC | GBR | GBP | 2023-12 | 45.80 | 3.2% | -0.6% | 0.7% | 1.4% | -0.6% | 13.4% | 22.3% | 15.7% | 6 | 5 | 1 | 1 | |||
| Eli Lilly and Co | USA | USD | 2023-12 | 34.12 | 28.1% | 32.4% | 31.0% | 19.6% | 19.6% | 9.8% | 11.6% | 9.7% | 1 | 1 | 4 | 4 | |||
| Amgen Inc | USA | USD | 2023-12 | 28.19 | 19.8% | 11.9% | 10.0% | 7.1% | 7.1% | 4.2% | 3.5% | 3.5% | 2 | 2 | 6 | 7 | |||
| Source: Annual Filings, Company Website | |||||||||||||||||||